ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer

Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to disease progression are poorly understood. Extensive gene expression correlation analysis, quantitative multiplex imaging of clinical samples...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2018-02, Vol.8 (1), p.2338-14, Article 2338
Hauptverfasser: Pellinen, Teijo, Blom, Sami, Sánchez, Sara, Välimäki, Katja, Mpindi, John-Patrick, Azegrouz, Hind, Strippoli, Raffaele, Nieto, Raquel, Vitón, Mariano, Palacios, Irene, Turkki, Riku, Wang, Yinhai, Sánchez-Alvarez, Miguel, Nordling, Stig, Bützow, Anna, Mirtti, Tuomas, Rannikko, Antti, Montoya, María C., Kallioniemi, Olli, del Pozo, Miguel A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14
container_issue 1
container_start_page 2338
container_title Scientific reports
container_volume 8
creator Pellinen, Teijo
Blom, Sami
Sánchez, Sara
Välimäki, Katja
Mpindi, John-Patrick
Azegrouz, Hind
Strippoli, Raffaele
Nieto, Raquel
Vitón, Mariano
Palacios, Irene
Turkki, Riku
Wang, Yinhai
Sánchez-Alvarez, Miguel
Nordling, Stig
Bützow, Anna
Mirtti, Tuomas
Rannikko, Antti
Montoya, María C.
Kallioniemi, Olli
del Pozo, Miguel A.
description Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to disease progression are poorly understood. Extensive gene expression correlation analysis, quantitative multiplex imaging of clinical samples, and analysis of the CAV1-dependent transcriptome, supported that CAV1 re-programmes TGFβ signalling from tumour suppressive to oncogenic (i.e. induction of SLUG, PAI-1 and suppression of CDH1, DSP, CDKN1A). Supporting such a role, CAV1 knockdown led to growth arrest and inhibition of cell invasion in prostate cancer cell lines. Rationalized RNAi screening and high-content microscopy in search for CAV1 upstream regulators revealed integrin beta1 (ITGB1) and integrin associated proteins as CAV1 regulators. Our work suggests TGFβ signalling and beta1 integrins as potential therapeutic targets in PCa over-expressing CAV1, and contributes to better understand the paradoxical dual role of TGFβ in tumour biology.
doi_str_mv 10.1038/s41598-018-20161-2
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_490755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1995159368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-e11b97d52703d7e6ac4d296e0b952acd4076eab1b74b81049a8fa7a113f5ca5e3</originalsourceid><addsrcrecordid>eNp1UsFu1DAQjRCIVqU_wAFZ4sLFYDt2El-QYEWXSpW4LGfLcSapS9YOdrJVJb6KD-GbGLpLtUXCl7E8b55n3ryieMnZW87K5l2WXOmGMt5QwXjFqXhSnAomFRWlEE-P7ifFec43DI8SWnL9vDjByISu-Gnx43Kz_shpBxOEDsJMlinBsIx29jGQ2JOV3UEcfaCc5Fs_u2vIZLO--PWTZD8EO2JqIH2KWzIv27gkmpcJKXL2OyBzJDG4OEDwjvhAphTzbGcgzgYH6UXxrLdjhvNDPCu-XnzarD7Tqy_ry9WHK-oUFzMFzltdd0rUrOxqqKyTHXYPrNVKWNdJVldgW97Wsm04k9o2va0t52WvnFVQnhV0z5tvYVpaMyW_tenOROvN4ekb3sBIzWqlEP9-j8fMFjqHuiQ7Pip7nAn-2gxxZ1StNa8lErw5EKT4fYE8m63PDsbRBohLNlxrhesrqwahr_-B3qCKKOw9SpZa4kiIEnuUQwVzgv6hGc7MHz-YvR8M-sHc-8EILHp1PMZDyd_tI6A86IKpMEA6-vv_tL8BB8PEMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1994394810</pqid></control><display><type>article</type><title>ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer</title><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature OA Free Journals</source><creator>Pellinen, Teijo ; Blom, Sami ; Sánchez, Sara ; Välimäki, Katja ; Mpindi, John-Patrick ; Azegrouz, Hind ; Strippoli, Raffaele ; Nieto, Raquel ; Vitón, Mariano ; Palacios, Irene ; Turkki, Riku ; Wang, Yinhai ; Sánchez-Alvarez, Miguel ; Nordling, Stig ; Bützow, Anna ; Mirtti, Tuomas ; Rannikko, Antti ; Montoya, María C. ; Kallioniemi, Olli ; del Pozo, Miguel A.</creator><creatorcontrib>Pellinen, Teijo ; Blom, Sami ; Sánchez, Sara ; Välimäki, Katja ; Mpindi, John-Patrick ; Azegrouz, Hind ; Strippoli, Raffaele ; Nieto, Raquel ; Vitón, Mariano ; Palacios, Irene ; Turkki, Riku ; Wang, Yinhai ; Sánchez-Alvarez, Miguel ; Nordling, Stig ; Bützow, Anna ; Mirtti, Tuomas ; Rannikko, Antti ; Montoya, María C. ; Kallioniemi, Olli ; del Pozo, Miguel A.</creatorcontrib><description>Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to disease progression are poorly understood. Extensive gene expression correlation analysis, quantitative multiplex imaging of clinical samples, and analysis of the CAV1-dependent transcriptome, supported that CAV1 re-programmes TGFβ signalling from tumour suppressive to oncogenic (i.e. induction of SLUG, PAI-1 and suppression of CDH1, DSP, CDKN1A). Supporting such a role, CAV1 knockdown led to growth arrest and inhibition of cell invasion in prostate cancer cell lines. Rationalized RNAi screening and high-content microscopy in search for CAV1 upstream regulators revealed integrin beta1 (ITGB1) and integrin associated proteins as CAV1 regulators. Our work suggests TGFβ signalling and beta1 integrins as potential therapeutic targets in PCa over-expressing CAV1, and contributes to better understand the paradoxical dual role of TGFβ in tumour biology.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-018-20161-2</identifier><identifier>PMID: 29402961</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13 ; 13/106 ; 13/51 ; 14 ; 14/1 ; 14/63 ; 38 ; 38/39 ; 38/89 ; 45/47 ; 631/553/2711 ; 631/67/1857 ; 631/80/304 ; 692/4017 ; 692/4025/1752 ; Adaptor Proteins, Signal Transducing ; Caveolin ; Caveolin 1 - metabolism ; Caveolin-1 ; Cell Line, Tumor ; Correlation analysis ; E-cadherin ; Gene expression ; Gene Expression Regulation, Neoplastic ; Humanities and Social Sciences ; Humans ; Integrins ; Intracellular Signaling Peptides and Proteins - metabolism ; Male ; Membrane Proteins - metabolism ; Molecular modelling ; multidisciplinary ; Oncogenes ; Phenotype ; Prostate cancer ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - metabolism ; RNA-mediated interference ; Science ; Science (multidisciplinary) ; Signal Transduction ; Transforming Growth Factor beta1 - metabolism ; Tumor cell lines ; Tumors ; Up-Regulation</subject><ispartof>Scientific reports, 2018-02, Vol.8 (1), p.2338-14, Article 2338</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-e11b97d52703d7e6ac4d296e0b952acd4076eab1b74b81049a8fa7a113f5ca5e3</citedby><cites>FETCH-LOGICAL-c512t-e11b97d52703d7e6ac4d296e0b952acd4076eab1b74b81049a8fa7a113f5ca5e3</cites><orcidid>0000-0002-3671-4932 ; 0000-0002-8690-6983 ; 0000-0002-3231-0332 ; 0000-0001-8878-7028 ; 0000-0003-0455-9891 ; 0000-0002-1878-8911</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799174/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799174/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29402961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:137597237$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Pellinen, Teijo</creatorcontrib><creatorcontrib>Blom, Sami</creatorcontrib><creatorcontrib>Sánchez, Sara</creatorcontrib><creatorcontrib>Välimäki, Katja</creatorcontrib><creatorcontrib>Mpindi, John-Patrick</creatorcontrib><creatorcontrib>Azegrouz, Hind</creatorcontrib><creatorcontrib>Strippoli, Raffaele</creatorcontrib><creatorcontrib>Nieto, Raquel</creatorcontrib><creatorcontrib>Vitón, Mariano</creatorcontrib><creatorcontrib>Palacios, Irene</creatorcontrib><creatorcontrib>Turkki, Riku</creatorcontrib><creatorcontrib>Wang, Yinhai</creatorcontrib><creatorcontrib>Sánchez-Alvarez, Miguel</creatorcontrib><creatorcontrib>Nordling, Stig</creatorcontrib><creatorcontrib>Bützow, Anna</creatorcontrib><creatorcontrib>Mirtti, Tuomas</creatorcontrib><creatorcontrib>Rannikko, Antti</creatorcontrib><creatorcontrib>Montoya, María C.</creatorcontrib><creatorcontrib>Kallioniemi, Olli</creatorcontrib><creatorcontrib>del Pozo, Miguel A.</creatorcontrib><title>ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to disease progression are poorly understood. Extensive gene expression correlation analysis, quantitative multiplex imaging of clinical samples, and analysis of the CAV1-dependent transcriptome, supported that CAV1 re-programmes TGFβ signalling from tumour suppressive to oncogenic (i.e. induction of SLUG, PAI-1 and suppression of CDH1, DSP, CDKN1A). Supporting such a role, CAV1 knockdown led to growth arrest and inhibition of cell invasion in prostate cancer cell lines. Rationalized RNAi screening and high-content microscopy in search for CAV1 upstream regulators revealed integrin beta1 (ITGB1) and integrin associated proteins as CAV1 regulators. Our work suggests TGFβ signalling and beta1 integrins as potential therapeutic targets in PCa over-expressing CAV1, and contributes to better understand the paradoxical dual role of TGFβ in tumour biology.</description><subject>13</subject><subject>13/106</subject><subject>13/51</subject><subject>14</subject><subject>14/1</subject><subject>14/63</subject><subject>38</subject><subject>38/39</subject><subject>38/89</subject><subject>45/47</subject><subject>631/553/2711</subject><subject>631/67/1857</subject><subject>631/80/304</subject><subject>692/4017</subject><subject>692/4025/1752</subject><subject>Adaptor Proteins, Signal Transducing</subject><subject>Caveolin</subject><subject>Caveolin 1 - metabolism</subject><subject>Caveolin-1</subject><subject>Cell Line, Tumor</subject><subject>Correlation analysis</subject><subject>E-cadherin</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Integrins</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>Male</subject><subject>Membrane Proteins - metabolism</subject><subject>Molecular modelling</subject><subject>multidisciplinary</subject><subject>Oncogenes</subject><subject>Phenotype</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>RNA-mediated interference</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal Transduction</subject><subject>Transforming Growth Factor beta1 - metabolism</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><subject>Up-Regulation</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><recordid>eNp1UsFu1DAQjRCIVqU_wAFZ4sLFYDt2El-QYEWXSpW4LGfLcSapS9YOdrJVJb6KD-GbGLpLtUXCl7E8b55n3ryieMnZW87K5l2WXOmGMt5QwXjFqXhSnAomFRWlEE-P7ifFec43DI8SWnL9vDjByISu-Gnx43Kz_shpBxOEDsJMlinBsIx29jGQ2JOV3UEcfaCc5Fs_u2vIZLO--PWTZD8EO2JqIH2KWzIv27gkmpcJKXL2OyBzJDG4OEDwjvhAphTzbGcgzgYH6UXxrLdjhvNDPCu-XnzarD7Tqy_ry9WHK-oUFzMFzltdd0rUrOxqqKyTHXYPrNVKWNdJVldgW97Wsm04k9o2va0t52WvnFVQnhV0z5tvYVpaMyW_tenOROvN4ekb3sBIzWqlEP9-j8fMFjqHuiQ7Pip7nAn-2gxxZ1StNa8lErw5EKT4fYE8m63PDsbRBohLNlxrhesrqwahr_-B3qCKKOw9SpZa4kiIEnuUQwVzgv6hGc7MHz-YvR8M-sHc-8EILHp1PMZDyd_tI6A86IKpMEA6-vv_tL8BB8PEMw</recordid><startdate>20180205</startdate><enddate>20180205</enddate><creator>Pellinen, Teijo</creator><creator>Blom, Sami</creator><creator>Sánchez, Sara</creator><creator>Välimäki, Katja</creator><creator>Mpindi, John-Patrick</creator><creator>Azegrouz, Hind</creator><creator>Strippoli, Raffaele</creator><creator>Nieto, Raquel</creator><creator>Vitón, Mariano</creator><creator>Palacios, Irene</creator><creator>Turkki, Riku</creator><creator>Wang, Yinhai</creator><creator>Sánchez-Alvarez, Miguel</creator><creator>Nordling, Stig</creator><creator>Bützow, Anna</creator><creator>Mirtti, Tuomas</creator><creator>Rannikko, Antti</creator><creator>Montoya, María C.</creator><creator>Kallioniemi, Olli</creator><creator>del Pozo, Miguel A.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-3671-4932</orcidid><orcidid>https://orcid.org/0000-0002-8690-6983</orcidid><orcidid>https://orcid.org/0000-0002-3231-0332</orcidid><orcidid>https://orcid.org/0000-0001-8878-7028</orcidid><orcidid>https://orcid.org/0000-0003-0455-9891</orcidid><orcidid>https://orcid.org/0000-0002-1878-8911</orcidid></search><sort><creationdate>20180205</creationdate><title>ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer</title><author>Pellinen, Teijo ; Blom, Sami ; Sánchez, Sara ; Välimäki, Katja ; Mpindi, John-Patrick ; Azegrouz, Hind ; Strippoli, Raffaele ; Nieto, Raquel ; Vitón, Mariano ; Palacios, Irene ; Turkki, Riku ; Wang, Yinhai ; Sánchez-Alvarez, Miguel ; Nordling, Stig ; Bützow, Anna ; Mirtti, Tuomas ; Rannikko, Antti ; Montoya, María C. ; Kallioniemi, Olli ; del Pozo, Miguel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-e11b97d52703d7e6ac4d296e0b952acd4076eab1b74b81049a8fa7a113f5ca5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>13</topic><topic>13/106</topic><topic>13/51</topic><topic>14</topic><topic>14/1</topic><topic>14/63</topic><topic>38</topic><topic>38/39</topic><topic>38/89</topic><topic>45/47</topic><topic>631/553/2711</topic><topic>631/67/1857</topic><topic>631/80/304</topic><topic>692/4017</topic><topic>692/4025/1752</topic><topic>Adaptor Proteins, Signal Transducing</topic><topic>Caveolin</topic><topic>Caveolin 1 - metabolism</topic><topic>Caveolin-1</topic><topic>Cell Line, Tumor</topic><topic>Correlation analysis</topic><topic>E-cadherin</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Integrins</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>Male</topic><topic>Membrane Proteins - metabolism</topic><topic>Molecular modelling</topic><topic>multidisciplinary</topic><topic>Oncogenes</topic><topic>Phenotype</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>RNA-mediated interference</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal Transduction</topic><topic>Transforming Growth Factor beta1 - metabolism</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pellinen, Teijo</creatorcontrib><creatorcontrib>Blom, Sami</creatorcontrib><creatorcontrib>Sánchez, Sara</creatorcontrib><creatorcontrib>Välimäki, Katja</creatorcontrib><creatorcontrib>Mpindi, John-Patrick</creatorcontrib><creatorcontrib>Azegrouz, Hind</creatorcontrib><creatorcontrib>Strippoli, Raffaele</creatorcontrib><creatorcontrib>Nieto, Raquel</creatorcontrib><creatorcontrib>Vitón, Mariano</creatorcontrib><creatorcontrib>Palacios, Irene</creatorcontrib><creatorcontrib>Turkki, Riku</creatorcontrib><creatorcontrib>Wang, Yinhai</creatorcontrib><creatorcontrib>Sánchez-Alvarez, Miguel</creatorcontrib><creatorcontrib>Nordling, Stig</creatorcontrib><creatorcontrib>Bützow, Anna</creatorcontrib><creatorcontrib>Mirtti, Tuomas</creatorcontrib><creatorcontrib>Rannikko, Antti</creatorcontrib><creatorcontrib>Montoya, María C.</creatorcontrib><creatorcontrib>Kallioniemi, Olli</creatorcontrib><creatorcontrib>del Pozo, Miguel A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pellinen, Teijo</au><au>Blom, Sami</au><au>Sánchez, Sara</au><au>Välimäki, Katja</au><au>Mpindi, John-Patrick</au><au>Azegrouz, Hind</au><au>Strippoli, Raffaele</au><au>Nieto, Raquel</au><au>Vitón, Mariano</au><au>Palacios, Irene</au><au>Turkki, Riku</au><au>Wang, Yinhai</au><au>Sánchez-Alvarez, Miguel</au><au>Nordling, Stig</au><au>Bützow, Anna</au><au>Mirtti, Tuomas</au><au>Rannikko, Antti</au><au>Montoya, María C.</au><au>Kallioniemi, Olli</au><au>del Pozo, Miguel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2018-02-05</date><risdate>2018</risdate><volume>8</volume><issue>1</issue><spage>2338</spage><epage>14</epage><pages>2338-14</pages><artnum>2338</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to disease progression are poorly understood. Extensive gene expression correlation analysis, quantitative multiplex imaging of clinical samples, and analysis of the CAV1-dependent transcriptome, supported that CAV1 re-programmes TGFβ signalling from tumour suppressive to oncogenic (i.e. induction of SLUG, PAI-1 and suppression of CDH1, DSP, CDKN1A). Supporting such a role, CAV1 knockdown led to growth arrest and inhibition of cell invasion in prostate cancer cell lines. Rationalized RNAi screening and high-content microscopy in search for CAV1 upstream regulators revealed integrin beta1 (ITGB1) and integrin associated proteins as CAV1 regulators. Our work suggests TGFβ signalling and beta1 integrins as potential therapeutic targets in PCa over-expressing CAV1, and contributes to better understand the paradoxical dual role of TGFβ in tumour biology.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29402961</pmid><doi>10.1038/s41598-018-20161-2</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-3671-4932</orcidid><orcidid>https://orcid.org/0000-0002-8690-6983</orcidid><orcidid>https://orcid.org/0000-0002-3231-0332</orcidid><orcidid>https://orcid.org/0000-0001-8878-7028</orcidid><orcidid>https://orcid.org/0000-0003-0455-9891</orcidid><orcidid>https://orcid.org/0000-0002-1878-8911</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2018-02, Vol.8 (1), p.2338-14, Article 2338
issn 2045-2322
2045-2322
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_490755
source MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; SWEPUB Freely available online; Free Full-Text Journals in Chemistry; Springer Nature OA Free Journals
subjects 13
13/106
13/51
14
14/1
14/63
38
38/39
38/89
45/47
631/553/2711
631/67/1857
631/80/304
692/4017
692/4025/1752
Adaptor Proteins, Signal Transducing
Caveolin
Caveolin 1 - metabolism
Caveolin-1
Cell Line, Tumor
Correlation analysis
E-cadherin
Gene expression
Gene Expression Regulation, Neoplastic
Humanities and Social Sciences
Humans
Integrins
Intracellular Signaling Peptides and Proteins - metabolism
Male
Membrane Proteins - metabolism
Molecular modelling
multidisciplinary
Oncogenes
Phenotype
Prostate cancer
Prostatic Neoplasms - genetics
Prostatic Neoplasms - metabolism
RNA-mediated interference
Science
Science (multidisciplinary)
Signal Transduction
Transforming Growth Factor beta1 - metabolism
Tumor cell lines
Tumors
Up-Regulation
title ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A46%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ITGB1-dependent%20upregulation%20of%20Caveolin-1%20switches%20TGF%CE%B2%20signalling%20from%20tumour-suppressive%20to%20oncogenic%20in%20prostate%20cancer&rft.jtitle=Scientific%20reports&rft.au=Pellinen,%20Teijo&rft.date=2018-02-05&rft.volume=8&rft.issue=1&rft.spage=2338&rft.epage=14&rft.pages=2338-14&rft.artnum=2338&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-018-20161-2&rft_dat=%3Cproquest_swepu%3E1995159368%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1994394810&rft_id=info:pmid/29402961&rfr_iscdi=true